FINWIRES · TerminalLIVE
FINWIRES

Canaccord Genuity Initiates Relay Therapeutics at Buy With $29 Price Target

By

Relay Therapeutics (RLAY) has an average rating of buy and mean price target of $25.38, according to analysts polled by FactSet.

What else is happening in Research?